Sign Out
Active ingredient: atezolizumab.
Tecentriq is supplied as a single-use vial containing preservative-free, colorless to slightly yellow solution, at an active ingredient concentration of 60 mg/ml, as follows: 14 mL vial containing a total of 840 mg atezolizumab; 20 mL vial containing a total of 1,200 mg atezolizumab.
Sterile/Radioactive Statement: Sterile product.
Excipients/Inactive Ingredients: as registered locally.
